15%Average body weight loss in clinical trials
- GLP-1 receptor agonist
- Once-weekly injection options
- Wegovy® approved for chronic weight management
- Ozempic® contains semaglutide for type 2 diabetes
You may qualify if:
- Adults with obesity or overweight seeking physician-guided treatment
- Patients whose BMI and medical history support GLP-1 therapy
- Individuals without contraindications identified during medical evaluation
- Patients in states where our licensed physicians provide telehealth (48 states)
- Those committed to ongoing medical supervision and lifestyle support
May not be appropriate if:
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy or planning to become pregnant
- History of serious allergic reaction to semaglutide
- Certain pancreatic or kidney conditions — determined by your physician
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Headache
- Fatigue
Serious side effects
- Pancreatitis (severe abdominal pain that may radiate to the back)
- Gallbladder problems
- Kidney problems or worsening kidney disease
- Serious allergic reactions
- Changes in vision (reported with rapid blood sugar improvement)
Connect with a licensed physician to see if semaglutide is the right fit for your weight loss goals.



